Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 9/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | DAO | P14920 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | YTHDF3 | Q7Z739 | 1/20 | 0.39 |
| ▸ | YTHDF1 | Q9BYJ9 | 1/20 | 0.39 |
| ▸ | YTHDF2 | Q9Y5A9 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28818278 | 0.98 | GPR84 (0.51) | GPR84CA1ALDH1A1DAOLMNA | |
| SCHEMBL2181657 | 0.82 | GPR84 (0.50) | GPR84CA1ALDH1A1LMNACYP1A2 | |
| SCHEMBL3475870 | 0.74 | GPR84 (0.44) | GPR84CA1ALDH1A1LMNACYP1A2 | |
| SCHEMBL27312293 | 0.73 | GAA (0.46) | GPR84CA1ALDH1A1DAOYTHDF3 | |
| SCHEMBL14656172 | 0.72 | GPR84 (0.69) | GPR84CA1ALDH1A1LMNACYP1A2 | |
| SCHEMBL60308 | 0.67 | — | — | |
| SCHEMBL8154152 | 0.66 | GPR84 (0.38) | GPR84CA1ALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL30618396 | 0.65 | CA1 (0.95) | GPR84CA1ALDH1A1LMNACYP1A2 | |
| Bromide SCHEMBL30618364 | 0.65 | CA1 (0.95) | GPR84CA1ALDH1A1LMNACYP1A2 | |
| SCHEMBL27323608 | 0.65 | CA1 (0.95) | GPR84CA1ALDH1A1LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106366677-A | Anticorrosion wood-plastic composite profile and preparation method thereof | 桂林舒康建材有限公司 | 2017-02-01 | — | — | CN | claimed |
| CN-103201355-B | Flame retardant compositions comprising triazine-intercalated metal phosphates | J.M.休伯有限公司 | 2016-08-17 | — | — | CN | claimed |
| CN-105315485-A | Organic transparent compound heat stabilizer, as well as preparation method and application thereof | UNIV ZHEJIANG TECHNOLOGY | 2016-02-10 | — | — | CN | claimed |
| US-8067391-B2 | ODCase inhibitors for the treatment of malaria | UNIVERSITY HEALTH NETWORK (CA) | 2011-11-29 | — | — | US | claimed |
| US-20090221524-A1 | ODCASE INHIBITORS FOR THE TREATMENT OF MALARIA | UNIVERSITY HEALTH NETWORK (CA) | 2009-09-03 | — | — | US | claimed |
| JP-7188023-A | — | — | None | — | — | JP | disclosed |
| CN-107501807-B | A kind of cold lamination film having highly resistance Ultraviolet Oxidation performance and anti-microbial property | 浙江越千树数码科技有限公司 | 2019-08-27 | — | — | CN | disclosed |
| CN-107501807-A | It is a kind of to possess high uvioresistant oxidation susceptibility and the cold lamination film of anti-microbial property | 浙江越千树数码科技有限公司 | 2017-12-22 | — | — | CN | disclosed |
| CN-106366677-A | Anticorrosion wood-plastic composite profile and preparation method thereof | 桂林舒康建材有限公司 | 2017-02-01 | — | — | CN | disclosed |
| EP-1931691-B1 | ODCASE INHIBITORS FOR THE TREATMENT OF MALARIA | UNIV HEALTH NETWORK (CA) | 2013-08-21 | — | — | EP | disclosed |
| US-8252490-B2 | Color filter and solid state imaging device having a colored pattern formed from a curable composition | FUJIFILM CORPORATION (JP) | 2012-08-28 | — | — | US | disclosed |
| US-8252490-B2 | Color filter and solid state imaging device having a colored pattern formed from a curable composition | FUJIFILM CORPORATION (JP) | 2012-08-28 | — | — | US | disclosed |
| US-20090017273-A1 | PIGMENT DISPERSION LIQUID, CURABLE COMPOSITION, COLOR FILTER PRODUCED USING THE SAME, AND SOLID STATE IMAGING DEVICE | FUJIFILM CORPORATION (JP) | 2009-01-15 | — | — | US | disclosed |
| EP-2013279-A1 | DERIVATIVES OF PYRIMIDINES AS FLAME RETARDANTS | Ciba Holding Inc. (CH) | 2009-01-14 | — | — | EP | disclosed |
| WO-2008083465-A1 | PYRIMIDINE DERIVATIVES AS ANTICANCER AGENTS | UNIVERSITY HEALTH NETWORK (CA) | 2008-07-17 | — | — | WO | disclosed |
| WO-2007128678-A1 | DERIVATIVES OF PYRIMIDINES AS FLAME RETARDANTS | CIBA HOLDING INC. (CH) | 2007-11-15 | — | — | WO | disclosed |
| EP-0967209-B1 | NH2-modified 6-aminouracils as stabilisers for halogen-containing polymers | CROMPTON VINYL ADDITIVES GMBH (DE) | 2003-01-08 | — | — | EP | disclosed |
| US-5859100-A | FILMS, PIPES; NONSTAINING | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-01-12 | — | — | US | disclosed |
| US-5859100-A | FILMS, PIPES; NONSTAINING | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-01-12 | — | — | US | disclosed |
| JP-H07188023-A | VASCULARIZATION INHIBITOR | TAIHO YAKUHIN KOGYO KK | 1995-07-25 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090221524-A1 | ODCASE INHIBITORS FOR THE TREATMENT OF MALARIA | UMPS, UGDH, UPP1 | GPR84 1000/4885CA1 4878/4885ALDH1A1 467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.